Peng A - Search Results

1

Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation.

Vo AA, Peng A, Toyoda M, Kahwaji J, Cao K, Lai CH, Reinsmoen NL, Villicana R, Jordan SC. Vo AA, et al. Among authors: peng a. Transplantation. 2010 May 15;89(9):1095-102. doi: 10.1097/TP.0b013e3181d21e7f. Transplantation. 2010. PMID: 20110854

2

Dual kidneys from marginal adult donors as a source for cadaveric renal transplantation in the United States.

Bunnapradist S, Gritsch HA, Peng A, Jordan SC, Cho YW. Bunnapradist S, et al. Among authors: peng a. J Am Soc Nephrol. 2003 Apr;14(4):1031-6. doi: 10.1097/01.asn.0000054494.85680.1c. J Am Soc Nephrol. 2003. PMID: 12660338

3

Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients.

Jordan SC, Vo A, Bunnapradist S, Toyoda M, Peng A, Puliyanda D, Kamil E, Tyan D. Jordan SC, et al. Among authors: peng a. Transplantation. 2003 Aug 27;76(4):631-6. doi: 10.1097/01.TP.0000080685.31697.FC. Transplantation. 2003. PMID: 12973100

4

Intravenous gammaglobulin (IVIG): a novel approach to improve transplant rates and outcomes in highly HLA-sensitized patients.

Jordan SC, Vo AA, Peng A, Toyoda M, Tyan D. Jordan SC, et al. Among authors: peng a. Am J Transplant. 2006 Mar;6(3):459-66. doi: 10.1111/j.1600-6143.2005.01214.x. Am J Transplant. 2006. PMID: 16468954 Free article. Review.

5

Effect of induction therapy protocols on transplant outcomes in crossmatch positive renal allograft recipients desensitized with IVIG.

Vo AA, Toyoda M, Peng A, Bunnapradist S, Lukovsky M, Jordan SC. Vo AA, et al. Among authors: peng a. Am J Transplant. 2006 Oct;6(10):2384-90. doi: 10.1111/j.1600-6143.2006.01472.x. Epub 2006 Jul 25. Am J Transplant. 2006. PMID: 16869794 Free article.

6

Alemtuzumab induction in kidney transplantation.

Huang E, Cho YW, Shah T, Peng A, Hayashi R, Bunnapradist S. Huang E, et al. Among authors: peng a. Clin Transpl. 2005:343-54. Clin Transpl. 2005. PMID: 17424750

7

The onset of rapidly progressive neurologic deterioration after a brief gastrointestinal illness in a renal allograft recipient.

Hristea I, Bunnapradist S, Peng A, Puliyanda D, Vo A, Jordan SC. Hristea I, et al. Among authors: peng a. Transpl Infect Dis. 2007 Jun;9(2):142-7. doi: 10.1111/j.1399-3062.2007.00211.x. Transpl Infect Dis. 2007. PMID: 17462001

8

Safety and adverse events profiles of intravenous gammaglobulin products used for immunomodulation: a single-center experience.

Vo AA, Cam V, Toyoda M, Puliyanda DP, Lukovsky M, Bunnapradist S, Peng A, Yang K, Jordan SC. Vo AA, et al. Among authors: peng a. Clin J Am Soc Nephrol. 2006 Jul;1(4):844-52. doi: 10.2215/CJN.01701105. Epub 2006 Apr 26. Clin J Am Soc Nephrol. 2006. PMID: 17699296

9

Analysis of subcutaneous (SQ) alemtuzumab induction therapy in highly sensitized patients desensitized with IVIG and rituximab.

Vo AA, Wechsler EA, Wang J, Peng A, Toyoda M, Lukovsky M, Reinsmoen N, Jordan SC. Vo AA, et al. Among authors: peng a. Am J Transplant. 2008 Jan;8(1):144-9. doi: 10.1111/j.1600-6143.2007.02017.x. Epub 2007 Oct 31. Am J Transplant. 2008. PMID: 17973966 Free article.

10

Rituximab and intravenous immune globulin for desensitization during renal transplantation.

Vo AA, Lukovsky M, Toyoda M, Wang J, Reinsmoen NL, Lai CH, Peng A, Villicana R, Jordan SC. Vo AA, et al. Among authors: peng a. N Engl J Med. 2008 Jul 17;359(3):242-51. doi: 10.1056/NEJMoa0707894. N Engl J Med. 2008. PMID: 18635429 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,096 results

Search Page

Filters